Completed
The number of genome-based diagnostic tests that have the potential to predict onset of disease or direct drug therapy has steadily increased as improved gene-disease relationships have been identified. However, few have been adopted for use in a health care setting. Given the current challenges, this workshop focused on identifying potential solutions in reimbursement policy, regulatory policy, and generating evidence of clinical utility to advance the development of clinically useful genomics-based diagnostic tests.
Featured publication
The sequencing of the human genome and the identification of associations between specific genetic variants and diseases have led to an explosion of genomic-based diagnostic tests. These tests have the potential to direct therapeutic interventions, predict risk or onset of disease, or detect residua...
View details